Prescribing errors by junior doctors- A comparison of errors with high risk medicines and non-high risk medicines

被引:14
作者
Alanazi, Mahdi A. [1 ,2 ]
Tully, Mary P. [1 ]
Lewis, Penny J. [1 ]
机构
[1] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Pharm & Optometry, Manchester, Lancs, England
[2] PSMMC, Pharmaceut Serv, Riyadh, Saudi Arabia
来源
PLOS ONE | 2019年 / 14卷 / 01期
关键词
IN-HOSPITAL INPATIENTS; ADVERSE DRUG EVENTS; MEDICATION ERRORS; PREVALENCE; WORKING; IMPACT;
D O I
10.1371/journal.pone.0211270
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Prescribing errors in hospital are common. However, errors with high-risk-medicines (HRMs) have a greater propensity to cause harm compared to non-HRMs. We do not know if there are differences between the causes of errors with HRMs and non-HRMs but such knowledge might be useful in developing interventions to reduce errors and avoidable harm. Therefore, this study aims to compare and contrast junior doctors' prescribing errors with HRMs to non-HRMs to establish any differences. Methods A secondary analysis of fifty-nine interviews with foundation year doctors, obtained from three studies, was conducted. Using a Framework Analysis approach, through NVivo software, a detailed comparison was conducted between the unsafe acts, error-causing-conditions (ECCs), latent conditions, and types of errors related to prescribing errors with HRMs and non-HRMs. Results In relation to unsafe acts, violations were described in the data with non-HRMs only. Differences in ECCs of HRMs and non-HRMs were identified and related to the complexity of prescribing HRMs, especially dosage calculations. There were also differences in the circumstances of communication failures: with HRMs ineffective communication arose with exchanges with individuals outside the immediate medical team while with non-HRMs these failures occurred with exchanges within that team. Differences were identified with the latent conditions: with non-HRMs there was a reluctance to seek seniors help and with HRMs latent conditions related to the organisational system such as the inclusion of trade names in hospital formularies. Moreover, prescribing during the on-call period was particularly challenging especially with HRMs. Conclusion From this secondary analysis, differences in the nature and type of prescribing errors with HRMs and non-HRMs were identified, although further research is needed to investigate their prevalence. As errors with HRMs have the potential to cause great harm it may be appropriate to target limited resources towards interventions that tackle the underlying causes of such errors. Equally concerning, however, was the sense that doctors regard the prescribing of non-HRMs as 'safe'.
引用
收藏
页数:17
相关论文
共 51 条
  • [1] A systematic review of the prevalence and incidence of prescribing errors with high-risk medicines in hospitals
    Alanazi, M. A.
    Tully, M. P.
    Lewis, P. J.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 239 - 245
  • [2] [Anonymous], 2018, List of High-Alert Medications in Acute Care Settings
  • [3] [Anonymous], 2016, NVIVO QUAL DAT AN SO, DOI [10.1111/j.1365-2125.2012.04313.x, DOI 10.1111/J.1365-2125.2012.04313.X]
  • [4] [Anonymous], 2009, GEN MEDICAL COUNCI
  • [5] Prevalence, Nature, Severity and Risk Factors for Prescribing Errors in Hospital Inpatients: Prospective Study in 20 UK Hospitals
    Ashcroft, Darren M.
    Lewis, Penny J.
    Tully, Mary P.
    Farragher, Tracey M.
    Taylor, David
    Wass, Valerie
    Williams, Steven D.
    Dornan, Tim
    [J]. DRUG SAFETY, 2015, 38 (09) : 833 - 843
  • [6] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [7] The costs of adverse drug events in hospitalized patients
    Bates, DW
    Spell, N
    Cullen, DJ
    Burdick, E
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Leape, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04): : 307 - 311
  • [8] Direct observation approach for detecting medication errors and adverse drug events in a pediatric intensive care unit
    Buckley, Mitchell S.
    Erstad, Brian L.
    Kopp, Brian J.
    Theodorou, Andreas A.
    Priestley, Gail
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (02) : 145 - 152
  • [9] Cheng Hui G, 2014, Shanghai Arch Psychiatry, V26, P371, DOI 10.11919/j.issn.1002-0829.214171
  • [10] Adverse Drug Events Among Hospitalized Medicare Patients: Epidemiology and National Estimates from a New Approach to Surveillance
    Classen, David C.
    Jaser, Lisa
    Budnitz, Daniel S.
    [J]. JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2010, 36 (01) : 12 - +